Latest News
Histo-Scientific Research Laboratories Rebrands Following Merger with Vet Path Services
Thursday 14 March 2019

14 March 2019 - US-based research and pre-clinical histology, pathology, and archiving services provider Histo-Scientific Research Laboratories, Inc. is rebranding following a merger with Vet Path Services and an accompanying growth investment from Ampersand Capital Partners, the company said.

The company will now be known as StageBio.

According to the principals, the merger of HSRL and VPS is an example of what is to come for StageBio.

The company is now positioned to provide its customers with fully integrated histopathology services including tissue analysis, efficacy determination for new compounds and devices, toxicological evaluation of products subject to FDA approval, detailed pathology reporting for GLP studies, medical device pathology, and immunohistochemistry.

This new brand and company is being formally launched at the Society of Toxicology meeting in Baltimore, March 10-14.

StageBio is the provider of GLP-compliant research and preclinical histology, pathology and specimen archiving services for the biopharmaceutical, medical device and contract research industries.

The company operates three sites in the US, with substantial continued investment in our facility and technology infrastructures to meet the growing demand for high-quality histopathology services.

StageBio has 20 board-certified veterinary pathologists and over 50 laboratory technicians on staff.
Date Published: 14/03/2019
Target: Vet Path Services
Country: USA
Sector: Healthcare
Type: LBO
Status: Closed
Buyer: Histo-Scientific Research Laboratories
Terms of the deal were not disclosed